Rocket Lab (NASDAQ:RKLB) Stock Price Down 4.6% – Here’s What Happened

Shares of Rocket Lab Corporation (NASDAQ:RKLB) fell 4.6% during trading on Thursday. The stock traded as low as $49.96 and last traded at $51.22. Approximately 16,521,831 shares were traded during mid-day trading, a decline of 28% from the average session volume of 22,984,588 shares. The stock had previously closed at $53.67.

Trending Headlines about Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab’s core business remains supported by space-systems sales and launch activity, meaning the company is not entirely dependent on Neutron for near-term revenue. Some investors view the recent pullback as a more attractive entry point. Rocket Lab Just Had Another Setback: Here’s Why I’m Finally Buying the Stock Anyway
• Positive Sentiment: ARK Invest continued buying Rocket Lab shares despite the Neutron delay, signaling that some growth-oriented investors remain confident in the company’s long-term launch and space-infrastructure opportunity. Cathie Wood Trimmed Ark’s Alphabet Stake While Buying Rocket Lab
• Positive Sentiment: Wall Street analysts continue to cite significant potential upside, and Cantor Fitzgerald maintained its Buy rating. Rocket Lab’s upcoming third-quarter report on November 9 could provide a catalyst if revenue and guidance remain strong. 2 Nasdaq-100 Stocks to Buy Before They Soar
• Neutral Sentiment: A NASA-linked Mars mission involving Rocket Lab is drawing attention and could reinforce the company’s technical credibility, but its financial impact is likely longer term. Rocket Lab Mars Maneuver
• Negative Sentiment: Rocket Lab pushed Neutron’s first launch to 2027 after discovering manufacturing defects in carbon-fiber components. The delay raises concerns about development costs, cash-flow timing and whether projected Neutron-driven growth should be deferred. Rocket Lab Stock Plunged After a New Neutron Setback
• Negative Sentiment: Several reports argue that RKLB still trades at a premium valuation—about 26.6 times forward enterprise value to sales—despite the launch delay, leaving limited room for execution mistakes. Investors are also watching potential regulatory scrutiny of the proposed Iridium acquisition. Rocket Lab Stock Could Be Above Fair Value
• Negative Sentiment: The broader risk-off rotation out of high-flying technology and space stocks is intensifying selling across the sector, regardless of individual company results. Tech Selloff Hits High-Flying Space Stocks

Analysts Set New Price Targets

A number of research firms have weighed in on RKLB. Weiss Ratings reissued a “sell (d-)” rating on shares of Rocket Lab in a research report on Thursday, October 15th. Piper Sandler initiated coverage on shares of Rocket Lab in a research report on Wednesday, July 15th. They issued a “neutral” rating and a $83.00 price target on the stock. Wall Street Zen lowered shares of Rocket Lab from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. Berenberg Bank began coverage on shares of Rocket Lab in a research note on Wednesday, September 2nd. They issued a “buy” rating and a $83.00 price objective on the stock. Finally, Raymond James Financial started coverage on shares of Rocket Lab in a research report on Friday, September 11th. They set an “outperform” rating and a $80.00 price objective for the company. Three research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $102.05.

Rocket Lab Price Performance

The company has a market capitalization of $30.65 billion, a price-to-earnings ratio of -189.70 and a beta of 2.93. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48. The business has a 50 day moving average price of $67.15 and a 200-day moving average price of $83.95.

Rocket Lab (NASDAQ:RKLB) last announced its earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The business had revenue of $234.07 million for the quarter, compared to the consensus estimate of $231.62 million. Research analysts predict that Rocket Lab Corporation will post -0.20 EPS for the current fiscal year.

Insiders Place Their Bets

In other Rocket Lab news, insider Marvin Clevenger sold 15,051 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $1,048,001.13. Following the transaction, the insider directly owned 458,924 shares of the company’s stock, valued at approximately $31,954,878.12. The trade was a 3.18% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Frank Klein sold 35,558 shares of the stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $66.61, for a total value of $2,368,518.38. Following the transaction, the insider owned 925,737 shares in the company, valued at $61,663,341.57. The trade was a 3.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 400,749 shares of company stock valued at $26,964,474 in the last 90 days. Company insiders own 8.40% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the stock. BlackRock Inc. bought a new position in Rocket Lab during the second quarter worth $4,124,970,000. Bank of America Corp DE acquired a new stake in Rocket Lab in the second quarter worth $437,280,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Rocket Lab by 14.8% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,737,451 shares of the rocket manufacturer’s stock valued at $278,262,000 after purchasing an additional 352,094 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in Rocket Lab in the second quarter valued at $245,764,000. Finally, Amundi raised its holdings in shares of Rocket Lab by 22.2% during the second quarter. Amundi now owns 2,180,748 shares of the rocket manufacturer’s stock valued at $221,673,000 after purchasing an additional 396,639 shares during the period. Institutional investors and hedge funds own 71.78% of the company’s stock.

About Rocket Lab

Rocket Lab USA, Inc is a space and defense company that develops and operates launch vehicles, spacecraft, satellite components and related space systems. The company serves government, commercial and scientific customers seeking access to orbit and other space-based capabilities.

Rocket Lab’s launch business is centered on Electron, a small orbital launch vehicle designed to carry satellites and other payloads into low Earth orbit. The company also develops specialized launch and hypersonic test services through programs such as HASTE, while its Neutron vehicle is intended to provide larger payload capacity and support future commercial and government missions.

Through its space systems business, Rocket Lab produces satellite platforms, flight computers, power systems, solar cells, reaction wheels, separation systems, radios and other components used in spacecraft.